Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial - Top-Institutions - MDSpire

Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial

  • By

  • Christian S. Hendershot

  • Michael P. Bremmer

  • Michael B. Paladino

  • Georgios Kostantinis

  • Thomas A. Gilmore

  • Neil R. Sullivan

  • Amanda C. Tow

  • Mark A. Prince

  • Sarah S. Dermody

  • Robyn Jordan

  • Sherry A. McKee

  • Paul J. Fletcher

  • Eric D. Claus

  • Klara R. Klein

  • May 26, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    University of North Carolina-Chapel Hill
    University of North Carolina-Chapel Hill

    Chapel Hill, North Carolina

    Key Differentiators

    • Endocrinology

  • #2

    Stopping Atherosclerosis and Treating Unhealthy bone with RosuvastatiN in HIV (SATURN-HIV)
    Stopping Atherosclerosis and Treating Unhealthy bone with RosuvastatiN in HIV (SATURN-HIV)

    N/A, N/A

    Key Differentiators

    • Endocrinology

  • #3

    randomized trial to prevent vascular events in HIV (REPRIEVE)
    randomized trial to prevent vascular events in HIV (REPRIEVE)

    N/A, N/A

    Key Differentiators

    • Endocrinology

  • #4

    Mental Health Centre Copenhagen
    Mental Health Centre Copenhagen

    Copenhagen, Denmark

    Key Differentiators

    • Endocrinology

  • #5

    Copenhagen University Hospital–Bispebjerg and Frederiksberg
    Copenhagen University Hospital–Bispebjerg and Frederiksberg

    Copenhagen, Denmark

    Key Differentiators

    • Endocrinology

Original Source(s)

Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial

  • by Christian S. Hendershot, Michael P. Bremmer, Michael B. Paladino, Georgios Kostantinis, Thomas A. Gilmore, Neil R. Sullivan, Amanda C. Tow, Mark A. Prince, Sarah S. Dermody, Robyn Jordan, Sherry A. McKee, Paul J. Fletcher, Eric D. Claus, Klara R. Klein

  • May 26, 2026

Related Content

Test-Retest Reliability of Standardized Diagnostic Interviews for Common Adult Psychiatric Disorders: A

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam